CureMetrix is committed to the advancement of technology that improves disease detection and survival rates worldwide. Our AI-based products and research leverage artificial intelligence and deep learning to develop next-generation medical image analysis technology that radiologists and patients can confidently rely on.

Our powerful image analysis platform serves as an adjunct, precision tool for mammography. We equip radiologists with objective, data-driven answers to support patients and their healthcare teams in health decisions. We believe providing advanced technology for mammogram evaluation leads to improved clinical outcomes, reduced healthcare costs, and increased assurance that patients receive the highest standard of care.

Founded in 2014, CureMetrix has developed products with high efficacy, easy installation, and compatibility within existing clinical workflows. Our partnerships with radiologists, cardiologists, and esteemed institutions worldwide have collected over 5 million images for training and validating algorithms. We focus on improving outcomes from breast cancer to heart disease and kidney disease, extending the impact and value of screening programs globally through AI.

Industry: Hospitals and Health Care

Headquarters: San Diego, CA

Company size: 11-50 employees

Type: Privately Held

Founded: 2014

Mammography, healthcare, women's health, imaging, breast cancer, artificial intelligence, deep learning, computer software, healthcare technology